Epigenetics Market Projected to Surpass $5.47 Billion in Value by 2030
|
|
Meticulous
Research®, a preeminent global market research entity, has unveiled its latest
research report, titled 'Epigenetics
Market by Offering (Kits, Reagents, Instruments, Software), Method (DNA
Methylation, PCR, Chromatin Analysis, Histone, RNA Modification), Application
(Oncology, Non-oncology), and End User (Pharma, Academics, Hospitals) – Global
Forecast to 2030.' This comprehensive publication projects the global
epigenetics market to attain a valuation of $5.47 billion by the year 2030,
reflecting a remarkable Compound Annual Growth Rate (CAGR) of 15.7%.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5628
The surge in chronic diseases due to an
aging population, escalating cancer prevalence, increased pharmaceutical
Research and Development (R&D) expenditures, a heightened focus on
epigenetics in drug discovery and development, and reduced costs associated
with genome sequencing collectively propel the market's growth trajectory.
However, the dearth of skilled professionals poses a notable constraint to the
market's expansion.
The expanding applications of epigenetics
in non-oncology diseases, coupled with governmental support for large-scale
genomic sequencing initiatives, are anticipated to create favorable growth
opportunities for stakeholders. Nevertheless, challenges such as
standardization concerns related to epigenetics procedures and limited
applications in toxicology present significant obstacles to market
progression.
Key Players
Key industry players shaping the global
epigenetics market include Thermo Fisher Scientific Inc. (U.S.), Merck KGaA
(Germany), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherlands), and others.
The future outlook of the epigenetics
market is segmented by offering (Kits & Reagents, Services, Software),
method (DNA Methylation, Histone Modification, RNA Modification, PCR,
Chromatin Analysis, and other methods), application (Oncology, Non-oncology),
and end user (Biotechnology & Pharmaceutical Companies, Academic &
Research Institutes, Hospitals & Diagnostic Laboratories). The report
thoroughly assesses industry competitors and analyzes their global and
regional market shares.
In 2023, the kits & reagents segment
is projected to dominate the epigenetics market, with kits & assays
leading in growth, attributed to their repetitive use and advancements in
sequencing, mi-RNA, and real-time PCR technologies. Meanwhile, the DNA
methylation segment, specifically high-resolution melt (HRM) analysis, is
expected to experience the highest growth in the methods category, driven by
its qualitative analysis capabilities and advancements in real-time PCR
technology.
The oncology segment is forecasted to
command the largest market share among applications in 2023, owing to the
global burden of cancer, government and organizational initiatives, and
ongoing advances in cancer research. Within end users, the pharmaceutical and
biotechnology companies segment is anticipated to hold the largest share in
2023, fueled by increased demand for research-related products and rising
R&D expenditures.
Top 10 Companies Operating in Epigenetics Market: https://meticulousblog.org/top-10-companies-in-epigenetics-market/
Geographically, Asia-Pacific is poised to
exhibit the highest CAGR during the forecast period, driven by government
initiatives for genetic diseases, a growing incidence of cancer, an aging
population, increased R&D spending, and rising healthcare expenditure.
This comprehensive research report
provides insights into high-growth market segments, historical market trends,
forecasts for the period 2023–2030, major market drivers, challenges,
opportunities, and trends. It also delves into the competitive landscape,
identifying market leaders, recent developments, and strategies adopted by
major players. The report covers geographical trends, highlighting high-growth
regions and countries. For a detailed understanding, interested parties can
access the sample report here.
About Meticulous Research®
Meticulous Research® was founded in 2010
and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private
limited company under the Companies Act, 1956. Since its incorporation, the
company has become the leading provider of premium market intelligence in
North America, Europe, Asia-Pacific, Latin America, and the Middle East &
Africa.
The name of our company defines our
services, strengths, and values. Since the inception, we have only thrived to
research, analyze, and present the critical market data with great attention
to details. With the meticulous primary and secondary research techniques, we
have built strong capabilities in data collection, interpretation, and
analysis of data including qualitative and quantitative research with the
finest team of analysts. We design our meticulously analyzed intelligent and
value-driven syndicate market research reports, custom studies, quick
turnaround research, and consulting solutions to address business challenges
of sustainable growth.
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment